Procter & Gamble Hygiene and Health Care Ltd
Procter & Gamble Hygiene and Health Care Q4 FY25 earnings call: Revenue & Margins
Q4 FY25 earnings call: what management guided on revenue, margins and order book.
The short version
The company aims to grow ahead of the industry average, focusing on consistent and sustained growth rooted in a deep understanding of evolving consumer needs. The company aims to grow at a rate ahead of the industry average with consistent, sustained growth rooted in a deep understanding of evolving consumer needs and superior propositions.
From Procter & Gamble Hygiene and Health Care Ltd's Q4 FY25 earnings-call transcript · updated 23 Aug 2026.
Revenue & Sales Performance
- The company aims to grow ahead of the industry average, focusing on consistent and sustained growth rooted in a deep understanding of evolving consumer needs.
- Growth strategy centers on driving category expansion by uncovering and serving new "jobs to be done" for consumers.
- Significant opportunity exists to grow consumption and innovation within existing categories, particularly by increasing household penetration among unserved and underserved consumers.
- Innovation pipeline is robust, with recent quarters showing strong new product introductions designed to attract new users and address new consumer needs.
- Feminine care category has substantial runway as penetration is under 50%, with market leadership maintained and growth driven by product upgrades and education.
- Healthcare category innovations such as Vicks Steam Pods and Zzzquil are seeing positive market response, supporting growth.
2 more points management made on revenue & sales performance
Profitability & Margins
See what Procter & Gamble Hygiene and Health Care Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
2 more points management made on capital expenditure plans
Top-ranked in Personal Products
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Procter & Gamble Hygiene and Health Care Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
2 more points management made on order book & pipeline
Procter & Gamble Hygiene and Health Care Ltd — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest: revenue ₹941 Cr, net profit ₹153 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Procter & Gamble Hygiene and Health Care Ltd's management said in earlier quarters
Others in Personal Products this season
- Cupid Ltd (Q4 FY25)
125 crores by FY26, indicating +150% growth (Page 29, 18). Key concall takeaways from Cupid Ltd's Q4 FY25 earnings call — and how it ranks against sector peers.
- Gillette India Ltd (Q4 FY25)
Gillette India delivered a 12% sales growth and 40% profit growth in the past year, reflecting strong execution of their Integrated Growth Strategy. Key…
- Emami (Q4 FY25)
Dividend payouts were highlighted, with a total dividend of 1000% or Rs. Key concall takeaways from Emami Ltd's Q4 FY25 earnings call — and how it ranks…
- Colgate-Palmoliv (Q4 FY25)
The premium 30% urban segment remains resilient and continues to drive growth. Key concall takeaways from Colgate-Palmolive (India) Ltd's Q4 FY25 earnings call…
Frequently Asked Questions
What were Procter & Gamble Hygiene and Health Care Ltd Q4 FY25 results?
The company aims to grow ahead of the industry average, focusing on consistent and sustained growth rooted in a deep understanding of evolving consumer needs. The company aims to grow at a rate ahead of the industry average with consistent, sustained growth rooted in a deep understanding of evolving consumer needs and superior propositions.
What is Procter & Gamble Hygiene and Health Care Ltd share price analysis?
Procter & Gamble Hygiene and Health Care Ltd currently shows a neutral. The stock trades at a P/E of 34.8 with a market cap of ₹27,541 Cr. Investors should review the full earnings analysis for detailed insights.
Is Procter & Gamble Hygiene and Health Care Ltd planning capital expenditure?
The transcript does not explicitly mention any current or future capex, capital investment, or strategic investment plans.
Keep Procter & Gamble Hygiene and Health Care Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.